NCT06898749Recruiting
Impact of Canine Mediation Practice in Psychomotor Therapy on Improving the Quality of Life in Adult Epileptic Patients.
Source: ClinicalTrials.gov · Last updated 6 Oct 2026
Brief summary (registry, in English)
In addition to the search for new pharmaceutical or surgical solutions that could improve the therapeutic management of epileptic individuals, it is interesting to ask whether other complementary approaches, such as canine mediation in psychomotor therapy, could enhance the quality of life in this population. However, there is currently no evidence indicating that exposure to animals through mediation sessions would be beneficial for epileptic individuals, particularly regarding their quality of life, anxiety, emotional management, or cognition (such as social cognition). In the absence of current data in this population, it seems pertinent to study the impact of this practice on people with epilepsy. Furthermore, beyond quality of life, it would be valuable to examine whether it also influences anxiety or the frequency of seizures in individuals with epilepsy (a phenomenon reported for epileptic individuals living with a pet dog or a service dog). Canine mediation could help better manage and regulate the emotions of epileptic individuals, as well as improve their self-esteem.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 76 (estimated)
- First submitted
- 21 Mar 2025
- Start date
- 14 Sept 2026
- Primary completion date
- Mar 2030
- Lead sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Diseases
- Epilepsy
- NCT number
- NCT06898749
What you commit to
- Study type: Interventional
- Planned participants: 76
- From 14 Sept 2026 to the primary completion date, Mar 2030
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Fear or phobia of dogs
- Epileptic person benefiting from a legal protection measure other than guardianship or curatorship
- Person with insufficient cognitive abilities to respond to the questionnaires
- Pregnant or breastfeeding woman
Who the study is looking for
- Person aged ≥ 18 years
- Presenting pharmacoresistant epilepsy according to the criteria of the International League Against Epilepsy
- Requiring psychomotor therapy sessions for one of the following indications:
- Difficult emotional and relational management And/or global motor difficulties And/or body schema organization disorder And/or temporo-spatial disorder
- Explicit consent or no opposition to participation in the study by the patient and/or their legal representative or guardian
- Image rights consented by the patient and their legal representative or guardian, if applicable
- Hospitalization or residence at the Teppe Institute or at the FAM (Foyer d'Accueil Médicalisé) des 4 Jardins planned for at least 3 months
- Affiliated with or a beneficiary of a social security scheme
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fondation Partage et Vie - FAM Les Quatre Jardins Coordinator of this site? Confirm its status | Saint-Étienne-de-Saint-Geoirs | France | Not yet recruiting |
| Institut La Teppe Coordinator of this site? Confirm its status | Tain-l'Hermitage | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.